Migrena klinikiniai tyrimai New York
15 tyrimai dėl Migrena ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
Renkami dalyviai1 fazė
Amžius nuo 6 iki 11 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-28 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- University of Buffalo Medical Center, Buffalo
- Mount Sinai, New York
- Stony Brook University Medical Center, Stony Brook
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06735833A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06473597Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
Renkami dalyviai
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-09-21 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology, Commack
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-06-12 · NCT05164172Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-05-22 · NCT07061847RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
Renkami dalyviai
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2025-10-10 · NCT06077838Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.